PLSE Q2 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$265,000

Gross Profit

-$1M-407.2% margin

Operating Income

-$14M-5288.3% margin

Net Income

-$14M-5281.5% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

-40.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$41M

Total Liabilities

$17M

Stockholders' Equity

$23M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$265,000	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$14M	-$15M	+5.3%
Net Income	-$14M	-$15M	+8.7%